The increased expression of SphK2 preferentially located in the nucleus of AD brain may be harmful to the pathogenesis of AD, which may be related to the destruction of the protective effect of retinoic acid (Dominguez et al., 2018). This evidence concerns the gene SPHK2 and Alzheimer disease.